Related Experiment Video
Updated: Sep 21, 2025

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K
Kristin Franke1,2, Marieluise Kirchner3, Philipp Mertins3
1Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Background:
The SCF/KIT axis regulates nearly all aspects of mast cell (MC) biology. A comprehensive view of SCF-triggered phosphorylation dynamics is lacking. The relationship between signaling modules and SCF-supported functions likewise remains ill-defined.
Methods:
Mast cells were isolated from human skin; upon stimulation by SCF, global phosphoproteomic changes were analyzed by LC-MS/MS and selectively validated by immunoblotting. MC survival was inspected by YoPro; BrdU incorporation served to monitor proliferation. Gene expression was quantified by RT-qPCR and cytokines by ELISA. Pharmacological inhibitors were supplemented by ERK1 and/or ERK2 knockdown. CIC translocation and degradation were studied in nuclear and cytoplasmic fractions. CIC's impact on KIT signaling and function was assessed following RNA interference.
Results:
≈5400 out of ≈10,500 phosphosites experienced regulation by SCF. The MEK/ERK cascade was strongly induced surpassing STAT5 > PI3K/Akt > p38 > JNK. Comparison between MEK/ERK's and PI3K's support of basic programs (apoptosis, proliferation) revealed equipotency between modules. In functional outputs (gene expression, cytokines), ERK was the most influential kinase. OSM and LIF production was identified in skin MCs. Strikingly, SCF triggered massive phosphorylation of a protein not associated with KIT previously: CIC. Phosphorylation was followed by CIC's cytoplasmic appearance and degradation, the latter sensitive to protease but not preoteasome inhibition. Both shuttling and degradation were ERK-dependent. Conversely, CIC-siRNA facilitated KIT signaling, functional outputs, and survival.
Conclusion:
The SCF/KIT axis shows notable strength in MCs, and MEK/ERK as most prominent module. An inhibitory circuit exists between KIT and CIC. CIC stabilization in MCs may turn out as a therapeutic option to interfere with allergic and MC-driven diseases.
Insights
Stem cell factor (SCF) signaling via KIT is crucial for mast cell (MC) biology. This study reveals ERK as the dominant kinase pathway and identifies a novel inhibitory circuit involving CIC, offering therapeutic potential for allergic diseases.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The stem cell factor (SCF)/KIT signaling pathway is fundamental to mast cell (MC) biology.
- A detailed understanding of SCF-induced phosphorylation dynamics and its link to MC functions is currently lacking.
Purpose of the Study:
- To comprehensively map SCF-triggered phosphoproteomic changes in human mast cells.
- To elucidate the signaling pathways and molecular mechanisms underlying SCF/KIT-mediated mast cell functions.
- To identify novel regulators of KIT signaling and their therapeutic implications.
Main Methods:
- Isolation of human skin mast cells and stimulation with SCF.
- Global phosphoproteomic analysis using LC-MS/MS.
- Validation of phosphosites by immunoblotting.
- Assessment of mast cell survival, proliferation, gene expression, and cytokine production.
- Pharmacological inhibition and knockdown of key signaling molecules (e.g., ERK1/2).
- Investigation of CIC protein localization, degradation, and its impact on KIT signaling.
Main Results:
- SCF stimulation regulated approximately 5400 phosphosites, with the MEK/ERK cascade being the most prominent signaling pathway.
- ERK was identified as the most influential kinase in regulating mast cell functional outputs, including gene expression and cytokine production.
- A novel inhibitory circuit was discovered where SCF-induced phosphorylation leads to the cytoplasmic translocation and degradation of CIC, which in turn enhances KIT signaling and mast cell survival.
Conclusions:
- The SCF/KIT axis is a potent regulator of mast cell biology, with the MEK/ERK pathway playing a central role.
- A previously unrecognized inhibitory interaction between KIT signaling and CIC protein was identified.
- Targeting CIC stabilization in mast cells presents a potential therapeutic strategy for allergic and mast cell-mediated diseases.
Related Concept Videos
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
PI3K/mTOR/AKT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

